SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

BlackBerry Ltd. engages in the provision of intelligent security software and services. It operates through the following segments: QNX, Secure Communications, and Licensing. The QNX segment includes development of safe and reliable software for embedded systems across technology-driven industries. The Secure Communications segment delivers operational resiliency with a government-grade portfolio of secure, certified solutions for mobile fortification, critical communications and crisis management. The Licensing segment focuses on management and monetization of the firm's global patent portfolio. The company was founded by Michael Lazaridis, James Laurence Balsillie, and Douglas E. Fregin on March 7, 1984 and is headquartered in Waterloo, Canada.

BlackBerry Ltd

BlackBerrys stronger-than-expected Q2 results and raised fiscal-year outlook are driving attention, alongside record QNX performance and its first Alloy Kore design win with Coretura. Traders are largely encouraged, but some question how quickly the design-win backlog will convert to revenue and are frustrated that the shares have not responded more strongly.

Infleqtion, Inc. engages in delivering neutral atom solutions for quantum computing, networking, sensing, and security. Its products are categorized into computing, sensing, and cores. The company was founded on February 7, 2007, and is headquartered in Louisville, CO.

Infleqtion Inc. - Ordinary Shares - Class A

Infleqtion Inc.

Infleqtions reported demonstration of 30 entangled logical qubits working together on its commercial Sqale system is driving attention, with bullish traders calling it a meaningful quantum-computing milestone and comparing it favorably with competitors. Some debate the significance versus other companies research demonstrations, while others note that the stock has struggled to sustain momentum despite the news.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

Rising Treasury yields and inflation concerns are fueling expectations of further Fed tightening and weighing on SPY. Traders are split between warning of a deeper selloff and viewing the pullback as a buying opportunity, with some pointing to possible Treasury purchases as support.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

QQQ is under pressure as rising Treasury yields and expectations for further Fed tightening weigh on growth-heavy technology stocks, with oil and inflation concerns adding to the macro uncertainty. Traders are divided between expecting a deeper decline and buying the dip for another sharp rebound, with many also debating whether the volatile moves reflect algo-driven support.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, Peter Salanki, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeaves convertible-debt financing and share-sale program have put leverage and potential dilution at the center of discussion, with traders attributing recent weakness to the funding overhang. Bulls argue the capital will support expansion amid strong AI-compute demand and a large backlog, while skeptics question whether future cash flows will justify the debt and investment needs.

Iovance Biotherapeutics, Inc. engages in the development and commercialization of cell therapies using autologous tumor-infiltrating lymphocytes (TIL) for the treatment of cancer. Its products include Amtagvi (lifileucel), and Proleukin (aldesleukin). The firm also develops investigational TIL therapies for other solid tumor cancers. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.

Iovance Biotherapeutics Inc

Goldman Sachs resumption of coverage at Buy, citing improving Amtagvi launch execution and gross margins, is drawing attention, with some traders welcoming the endorsement and others questioning the firms reversal. The community is also focused on the pending revenue-guidance update and upcoming NSCLC data, while some investors express frustration over the guidance delay.

Quantinuum Inc. is a quantum computing platform that offers solutions like hardware platforms, developer tools, application libraries and solution-targeted intellectual property (“IP”). The company was founded on January 20, 2026 and is headquartered in Broomfield, CO.

Quantinuum Inc. - Ordinary Shares - Class A

Quantinuum Inc.

Quantinuums finalized federal CHIPS R&D award is a key catalyst, drawing attention to government support for its quantum-computing development and U.S. manufacturing plans. Traders are weighing that backing against concerns about the companys rich valuation and the stocks volatility.

McDonald's Corp. engages in the operation and franchising of restaurants. The firm operates through the following segments: U.S., International Operated Markets, and International Developmental Licensed Markets and Corporate. The U.S. segment focuses its operations on the United States. The International Operated Markets segment consists of operations and the franchising of restaurants in Australia, Canada, France, Germany, Italy, the Netherlands, Russia, Spain, and the U.K. The International Developmental Licensed Markets and Corporate segment consists of developmental licensee and affiliate markets in the McDonald’s system. Its products include Big Mac, Quarter Pounder with Cheese, Filet-O-Fish, several chicken sandwiches, Chicken McNuggets, wraps, McDonald's Fries, salads, oatmeal, shakes, McFlurry desserts, sundaes, soft serve cones, pies, soft drinks, coffee, and McCafe beverages. The company was founded by Raymond Albert Kroc on April 15, 1955 and is headquartered in Chicago, IL.

McDonald`s Corp

McDonald's Corp

McDonalds shares are drawing attention after its investor-day outlook combined plans for substantial restaurant investment with expectations of persistent inflation, flat industry traffic and slightly negative U.S. sales for the quarter. Traders are divided between viewing the steep selloff as an oversold buying opportunity and seeing continued pressure from weak traffic, affordability concerns and execution challenges.

Kyverna Therapeutics, Inc. is a cell therapy clinical-stage biotechnology company, which engages in the provision of treatments and potential cures for serious autoimmune diseases. The company was founded in June 2018 and is headquartered in Emeryville, CA.

Kyverna Therapeutics Inc.

iShares Trust - iShares 20+ Year Treasury Bond ETF

iShares 20+ Year Treasury Bond ETF

A sharp rise in Treasury yields, fueled by persistent inflation concerns, strong economic data and expectations of further Fed tightening, is weighing on long-duration TLT. Traders are broadly bearish after the selloff, though some are buying the dip and expecting a reversal; discussion also differs over whether inflation and Fed policy or heavy Treasury supply and fiscal concerns are driving the move.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
